A New Immunotherapy Combination Promises to Improve Survival for Patients with Metastatic Prostate Cancer

Juliette R Seremak; Bal L Lokeshwar

doi:10.3390/cancers15235640

A New Immunotherapy Combination Promises to Improve Survival for Patients with Metastatic Prostate Cancer

Cancers (Basel). 2023 Nov 29;15(23):5640. doi: 10.3390/cancers15235640.

Authors

Juliette R Seremak¹, Bal L Lokeshwar¹

Affiliation

¹ Georgia Cancer Center, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.

Abstract

Prostate cancer (PC) is the second-most prevalent malignancy affecting the male population worldwide [...].

Publication types

Editorial

Grants and funding

The work in the authors’ laboratories is supported by the Medical College of Georgia, J. Harold Harrison Foundation Chair (MCGFD00401) and the Startup funds from Georgia Cancer Center, Augusta University, Augusta GA (GG64550030).